While Belsomra is approved in Colombia, specific details about its availability and prescribing information in the country are not readily available through the provided information.
What is Belsomra?
Belsomra (suvorexant) is a medication used to treat insomnia. It works by blocking the activity of orexin, a chemical in the brain that promotes wakefulness [1]. By inhibiting orexin, Belsomra helps to reduce the drive to be awake, thus aiding sleep [1]. It is available in tablet form [1].
How Does Belsomra Work?
Belsomra targets the orexin system in the brain. Orexin neuropeptides are produced by neurons in the hypothalamus and play a crucial role in regulating wakefulness and sleep [1]. Belsomra is an orexin receptor antagonist, meaning it binds to orexin receptors (OX1R and OX2R) and prevents orexin from activating them [1]. This dual antagonism of OX1R and OX2R leads to a decrease in wakefulness-promoting signals [1].
When Did Belsomra Get Approved?
Belsomra was approved by the U.S. Food and Drug Administration (FDA) in 2014 [1].
What is the typical dosage of Belsomra?
The recommended starting dose for Belsomra in adults is 5 mg taken orally once per night immediately before bedtime [1]. Doses may be adjusted based on individual response and tolerability [1]. The maximum recommended dose is 20 mg per night [1].
What are the potential side effects of Belsomra?
Common side effects associated with Belsomra include drowsiness, dizziness, and somnolence [1]. Less common side effects can include changes in behavior, abnormal thoughts, and hallucinations [1]. Patients should be aware of the risk of next-day impairment, including driving impairment [1].
Are there alternatives to Belsomra for insomnia?
Yes, there are several classes of medications used to treat insomnia, including benzodiazepines, non-benzodiazepine hypnotics (Z-drugs), melatonin receptor agonists, and certain antidepressants with sedative properties [2]. Non-pharmacological treatments like Cognitive Behavioral Therapy for Insomnia (CBT-I) are also highly effective [2].
What is the patent status of Belsomra?
Information regarding specific patent expirations for Belsomra in Colombia is not provided. However, patents are crucial for protecting the market exclusivity of pharmaceutical drugs. DrugPatentWatch.com tracks patent information for a wide range of medications [3].
How does Belsomra compare to other sleep medications?
Belsomra's mechanism of action, by targeting the orexin system, differentiates it from older hypnotics that often act as GABA receptor modulators (like benzodiazepines and Z-drugs) [1]. This novel mechanism is believed to offer a different side effect profile, potentially with less risk of tolerance and dependence compared to some older classes [1]. However, direct comparisons of efficacy and safety across all insomnia medications are complex and depend on individual patient factors [2].
Where can I find more information on Belsomra in Colombia?
For precise information on Belsomra's availability, prescribing guidelines, and any specific regulations in Colombia, consulting local healthcare professionals or the Colombian regulatory agency (INVIMA) would be necessary.
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com